Peer Review History: Carnitine and its Derivatives as a Potential Option for Cardiovascular, Neurologic and Metabolic Complications of COVID-19

Editor(s):

(1) Dr. Mohamed Fawzy Ramadan Hassanien, Professor, Zagazig University, Egypt.

(2) Dr. Takashi Ikeno, National Cancer Center Hospital East, Japan.

Reviewers:

(1) Tamador Salem Maayah, Jordan Food and Drug Administration, Jordan.

(2) Salman Ahmed, University of Karachi, Pakistan.

(3) Ghaidaa A.Hafedh Jaber, University of Babylon, Iraq.

(4) Changping  Li, The Affiliated Hospital  of  Southwest Medical  University, China.

Additional Reviewers:

(1) Lucia Stančiaková, Comenius University in Bratislava, Slovak Republic.

(2) Sanaa Ali El-Benhawy, Alexandria Unversity, Egypt.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.62/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Tamador Salem Maayah, Jordan) | File 1 | NA


Stage 2 | Peer review report_2 (Salman Ahmed, Pakistan) | File 1 | NA


Stage 2 | Peer review report_3 (Ghaidaa A.Hafedh Jaber, Iraq) | File 1 | File 2


Stage 2 | Peer review report_4 (Changping Li, China) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA